Roche to shut UK R&D site

Published: 5-Jul-2001


F Hoffman-La Roche Ltd is to close its pharmaceutical research and development and manufacturing operations at Welwyn Garden City, Hertfordshire, with the loss of around 700 jobs.

The closure is part of a worldwide restructuring of Roche's pharmaceuticals division which will see up to 3,000 jobs lost over the next three years. Roche says that it has significant overcapacity in manufacturing as a result of changes to its product portfolio. It has decided to cease pharmaceutical manufacturing at Welwyn Garden City and chemical production at Basel, Switzerland.

See more

You may also like

Hi Tech Manufacturing

BES delivers live site pharma facility expansion to boost sterile production capacity

Read more
The controlled environment expert has completed an expansion of an operational plasma-derived medicines plant, delivering new Grade C cleanrooms and an upgraded high-speed filling line

Trending Articles

  1. Novartis cuts 550 jobs at Stein site in Switzerland reshuffle The pharmaceutical company has cut 550 jobs at its Stein site, while investing $80m in Schweizerhalle, after US tariffs are reduced on Swiss goods
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Eli Lilly to build $6bn API hub in Alabama amid GLP-1 demand surge Pharmaceutical giant has plans to invest $6bn to build a manufacturing facility in Alabama, which includes the production of GLP-1 receptor agonists to help with weight loss
  3. When to Replace your HEPA Filter – According to a Cleanroom Expert One of the most crucial elements in operating clean and sterile rooms is the use of HEPA filters, which are effective in capturing particles of almost all sizes. However, over time, HEPA filters lose their filtering capacity, which compromises the cleanliness of clean and sterile rooms or increases operational costs; therefore, their replacement is essential. The question is when? There is no exact answer, but KleanLabs' cleanroom experts shared their useful experience
  4. Cleanroom expert ClearSphere secures €6m to drive UK and Ireland expansion The cleanroom and containment specialist has secured funding from BGF to accelerate growth, expand capabilities and scale operations
  5. Eli Lilly Partners with NVIDIA to build pharma-focused AI supercomputer Lilly and NVIDIA have established a partnership to create a 1,000+ GPU AI supercomputer designed to transform drug discovery, clinical development and manufacturing

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Hi Tech Manufacturing

BES delivers live site pharma facility expansion to boost sterile production capacity

The controlled environment expert has completed an expansion of an operational plasma-derived medicines plant, delivering new Grade C cleanrooms and an upgraded high-speed filling line
Training & Education

Cleanroom Technology launches global cleanroom awards for 2026

Introducing the Cleanroom Technology Awards, the global benchmark for cleanroom excellence
Design & Build

Airkey delivers over 70 specialised pass boxes for global cleanroom projects

Custom static and dynamic pass throughs support critical contamination control across multiple industries
Design & Build

Guardtech Group celebrates record 2025 with global cleanroom expansion

A landmark year sees mobile, modular and GMP cleanrooms delivered across healthcare, pharma and microelectronics
Regulatory

AST academy expands services to support cGMP drug product manufacturing

New programme delivers training and CQV resources to accelerate pharmaceutical start-up
Regulatory

SRBA Group brings back Brecon name with 3-division restructure

The Dutch controlled environment specialist has split operations into three independent companies: SRBA Construction, SRBA Interior and Brecon Cleanroom Systems
You need to be a subscriber to read this article.
Click here to find out more.
Design & Build

Eli Lilly to build $6bn API hub in Alabama amid GLP-1 demand surge

Pharmaceutical giant has plans to invest $6bn to build a manufacturing facility in Alabama, which includes the production of GLP-1 receptor agonists to help with weight loss
Subscribe now